Challenges Raised by Biosimilars: Who is Responsible for Cost and Risk Management?

Francis Megerlin ()
Additional contact information
Francis Megerlin: CEIE - Centre d'études internationales et européennes - UNISTRA - Université de Strasbourg

Post-Print from HAL

Date: 2013
References: Add references at CitEc
Citations:

Published in Biosimilars. A New Generation of Biologics, Springer, 2013, 1-283-91060-8

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-05722612

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().